Disseminated and circulating tumor cells for monitoring chemotherapy in urological tumors

Anticancer Research

Volumn 31, Issue 6, 2011, Pages 2053-2057

  Kruck, Stephan ^a   Gakis, Georgios ^a   Stenzl, Arnulf ^a  

^a UNIVERSITY OF TÜBINGEN   (Germany)

Author keywords

Bladder cancer; Chemotherapy; Circulating tumor cells; Detection; Disseminated tumor cells; Prostate cancer; Renal cell carcinoma; Review

Indexed keywords

EPITHELIAL CELL ADHESION MOLECULE; PROSTATE SPECIFIC ANTIGEN;

BLADDER METASTASIS; BLOOD SAMPLING; CANCER CHEMOTHERAPY; CANCER DIAGNOSIS; CANCER GROWTH; CANCER PATIENT; CANCER SURVIVAL; CELL DENSITY; CELL SELECTION; CIRCULATING TUMOR CELL; DENSITY GRADIENT CENTRIFUGATION; DISSEMINATED TUMOR CELL; EPITHELIUM IMMUNOSPOT; GLEASON SCORE; HUMAN; IMMUNOASSAY; IMMUNOCYTOCHEMISTRY; IMMUNOMAGNETIC SEPARATION; KIDNEY CARCINOMA; LASER MICROSCOPY; OVERALL SURVIVAL; PRIORITY JOURNAL; PROGNOSIS; PROSTATE CANCER; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; REVIEW; SENSITIVITY AND SPECIFICITY; TRANSITIONAL CELL CARCINOMA; TREATMENT RESPONSE; TUMOR CELL;

CENTRIFUGATION, DENSITY GRADIENT; ENZYME-LINKED IMMUNOSPOT ASSAY; HUMANS; IMMUNOMAGNETIC SEPARATION; NEOPLASTIC CELLS, CIRCULATING; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; UROLOGIC NEOPLASMS;

EID: 79960448516     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (47)

1. Okajima E and Kotake T: Management of advanced urogenital cancer: treatment of metastasis. Hinyokika Kiyo 40: 905-907, 1994 (in Japanese).
2. Lugo TG, Braun S, Cote RJ, Pantel K and Rusch V: Detection and measurement of occult disease for the prognosis of solid tumors. J Clin Oncol 21: 2609-2615, 2003. (Pubitemid 46606345)
3. Funke I and Schraut W: Meta-analyses of studies on bone marrow micrometastases: an independent prognostic impact remains to be substantiated. J Clin Oncol 16: 557-566, 1998. (Pubitemid 28135599)
4. Pantel K and Brakenhoff RH: Dissecting the metastatic cascade. Nat Rev Cancer 4: 448-456, 2004. (Pubitemid 38745530)
5. Husemann Y, Geigl JB, Schubert F, Musiani P, Meyer M, Burghart E, Forni G, Eils R, Fehm T, Riethmuller G and Klein CA: Systemic spread is an early step in breast cancer. Cancer Cell 13: 58-68, 2008. (Pubitemid 350309740)
6. Paterlini-Brechot P and Benali NL: Circulating tumor cell (CTC) detection: clinical impact and future directions. Cancer Lett 253: 180-204, 2007. (Pubitemid 47017533)
7. Pantel K, Brakenhoff RH and Brandt B: Detection, clinical relevance and specific biological properties of disseminating tumour cells. Nat Rev Cancer 8: 329-340, 2008. (Pubitemid 351596394)
8. Asworth TR: A case of cancer in which cells similar to those in tumors were seen in the blood after death. Aust Med J 14: 146-149, 1869.
9. Bilkenroth U, Taubert H, Riemann D, Rebmann U, Heynemann H and Meye A: Detection and enrichment of disseminated renal carcinoma cells from peripheral blood by immunomagnetic cell separation. Int J Cancer 92: 577-582, 2001. (Pubitemid 32319433)
10. Masuda TA, Kataoka A, Ohno S, Murakami S, Mimori K, Utsunomiya T, Inoue H, Tsutsui S, Kinoshita J, Masuda N, Moriyama N and Mori M: Detection of occult cancer cells in peripheral blood and bone marrow by quantitative RT-PCR assay for cytokeratin-7 in breast cancer patients. Int J Oncol 26: 721-730, 2005.
11. Wiedswang G, Borgen E, Schirmer C, Karesen R, Kvalheim G, Nesland JM and Naume B: Comparison of the clinical significance of occult tumor cells in blood and bone marrow in breast cancer. Int J Cancer 118: 2013-2019, 2006.
12. Rosenberg R, Gertler R, Friederichs J, Fuehrer K, Dahm M, Phelps R, Thorban S, Nekarda H and Siewert JR: Comparison of two density gradient centrifugation systems for the enrichment of disseminated tumor cells in blood. Cytometry 49: 150-158, 2002. (Pubitemid 37087227)
13. Trzpis M, McLaughlin PM, de Leij LM and Harmsen MC: Epithelial cell adhesion molecule: more than a carcinoma marker and adhesion molecule. Am J Pathol 171: 386-395, 2007. (Pubitemid 47344671)
14. Wu CH, Lin SR, Hsieh JS, Chen FM, Lu CY, Yu FJ, Cheng TL, Huang TJ, Huang SY and Wang JY: Molecular detection of disseminated tumor cells in the peripheral blood of patients with gastric cancer: evaluation of their prognostic significance. Dis Markers 22: 103-109, 2006. (Pubitemid 43893788)
15. Gerges N, Rak J and Jabado N: New technologies for the detection of circulating tumour cells. Br Med Bull 94: 49-64, 2010.
16. de Bono JS, Scher HI, Montgomery RB, Parker C, Miller MC, Tissing H, Doyle GV, Terstappen LW, Pienta KJ and Raghavan D: Circulating tumor cells predict survival benefit from treatment in metastatic castration-resistant prostate cancer. Clin Cancer Res 14: 6302-6309, 2008.
17. Cristofanilli M, Broglio KR, Guarneri V, Jackson S, Fritsche HA, Islam R, Dawood S, Reuben JM, Kau SW, Lara JM, Krishnamurthy S, Ueno NT, Hortobagyi GN and Valero V: Circulating tumor cells in metastatic breast cancer: biologic staging beyond tumor burden. Clin Breast Cancer 7: 471-479, 2007. (Pubitemid 46424284)
18. Naoe M, Ogawa Y, Takeshita K, Iwamoto S and Miyazaki A: Use of the Cell Search Circulating Tumor Cell Test for monitoring urothelial cancer: two case reports of metastatic urothelial cancer. South Med J 101: 439-441, 2008. (Pubitemid 351507523)
19. Wind J, Tuynman JB, Tibbe AG, Swennenhuis JF, Richel DJ, van Berge Henegouwen MI and Bemelman WA: Circulating tumour cells during laparoscopic and open surgery for primary colonic cancer in portal and peripheral blood. Eur J Surg Oncol 35: 942-950, 2009.
20. Ghossein RA, Scher HI, Gerald WL, Kelly WK, Curley T, Amsterdam A, Zhang ZF and Rosai J: Detection of circulating tumor cells in patients with localized and metastatic prostatic carcinoma: clinical implications. J Clin Oncol 13: 1195-1200, 1995.
21. Seiden MV, Kantoff PW, Krithivas K, Propert K, Bryant M, Haltom E, Gaynes L, Kaplan I, Bubley G, DeWolf W et al: Detection of circulating tumor cells in men with localized prostate cancer. J Clin Oncol 12: 2634-2639, 1994. (Pubitemid 24379650)
22. Bossolasco P, Ricci C, Farina G, Soligo D, Pedretti D, Scanni A and Deliliers GL: Detection of micrometastatic cells in breast cancer by RT-pCR for the mammaglobin gene. Cancer Detect Prev 26: 60-63, 2002. (Pubitemid 36087183)
23. Helo P, Cronin AM, Danila DC, Wenske S, Gonzalez-Espinoza R, Anand A, Koscuiszka M, Vaananen RM, Pettersson K, Chun FK, Steuber T, Huland H, Guillonneau BD, Eastham JA, Scardino PT, Fleisher M, Scher HI and Lilja H: Circulating prostate tumor cells detected by reverse transcription-PCR in men with localized or castration-refractory prostate cancer: concordance with CellSearch assay and association with bone metastases and with survival. Clin Chem 55: 765-773, 2009.
24. Nagrath S, Sequist LV, Maheswaran S, Bell DW, Irimia D, Ulkus L, Smith MR, Kwak EL, Digumarthy S, Muzikansky A, Ryan P, Balis UJ, Tompkins RG, Haber DA and Toner M: Isolation of rare circulating tumour cells in cancer patients by microchip technology. Nature 450: 1235-1239, 2007.
25. Alix-Panabieres C, Vendrell JP, Pelle O, Rebillard X, Riethdorf S, Muller V, Fabbro M and Pantel K: Detection and characterization of putative metastatic precursor cells in cancer patients. Clin Chem 53: 537-539, 2007. (Pubitemid 46447957)
26. Allard WJ, Matera J, Miller MC, Repollet M, Connelly MC, Rao C, Tibbe AG, Uhr JW and Terstappen LW: Tumor cells circulate in the peripheral blood of all major carcinomas but not in healthy subjects or patients with nonmalignant diseases. Clin Cancer Res 10: 6897-6904, 2004. (Pubitemid 39383039)
27. Moreno JG, Miller MC, Gross S, Allard WJ, Gomella LG and Terstappen LW: Circulating tumor cells predict survival in patients with metastatic prostate cancer. Urology 65: 713-718, 2005. (Pubitemid 40523005)
28. Danila DC, Heller G, Gignac GA, Gonzalez-Espinoza R, Anand A, Tanaka E, Lilja H, Schwartz L, Larson S, Fleisher M and Scher HI: Circulating tumor cell number and prognosis in progressive castration-resistant prostate cancer. Clin Cancer Res 13: 7053-7058, 2007. (Pubitemid 350276887)
29. Halabi S, Vogelzang NJ, Kornblith AB, Ou SS, Kantoff PW, Dawson NA and Small EJ: Pain predicts overall survival in men with metastatic castration-refractory prostate cancer. J Clin Oncol 26: 2544-2549, 2008.
30. Ramiah V, George DJ and Armstrong AJ: Clinical endpoints for drug development in prostate cancer. Curr Opin Urol 18: 303-308, 2008.
31. Scher HI, Jia X, de Bono JS, Fleisher M, Pienta KJ, Raghavan D and Heller G: Circulating tumour cells as prognostic markers in progressive, castration-resistant prostate cancer: a reanalysis of IMMC38 trial data. Lancet Oncol 10: 233-239, 2009.
32. Shaffer DR, Leversha MA, Danila DC, Lin O, Gonzalez-Espinoza R, Gu B, Anand A, Smith K, Maslak P, Doyle GV, Terstappen LW, Lilja H, Heller G, Fleisher M and Scher HI: Circulating tumor cell analysis in patients with progressive castration-resistant prostate cancer. Clin Cancer Res 13: 2023-2029, 2007.
33. Chen BT, Loberg RD, Neeley CK, O'Hara SM, Gross S, Doyle G, Dunn RL, Kalikin LM and Pienta KJ: Preliminary study of immunomagnetic quantification of circulating tumor cells in patients with advanced disease. Urology 65: 616-621, 2005. (Pubitemid 40386036)
34. Schwarzenbach H, Alix-Panabieres C, Muller I, Letang N, Vendrell JP, Rebillard X and Pantel K: Cell-free tumor DNA in blood plasma as a marker for circulating tumor cells in prostate cancer. Clin Cancer Res 15: 1032-1038, 2009.
35. Meye A, Bilkenroth U, Schmidt U, Fussel S, Robel K, Melchior AM, Blumke K, Pinkert D, Bartel F, Linne C, Taubert H and Wirth MP: Isolation and enrichment of urologic tumor cells in blood samples by a semi-automated CD45 depletion autoMACS protocol. Int J Oncol 21: 521-530, 2002.
36. Bluemke K, Bilkenroth U, Meye A, Fuessel S, Lautenschlaeger C, Goebel S, Melchior A, Heynemann H, Fornara P and Taubert H: Detection of circulating tumor cells in peripheral blood of patients with renal cell carcinoma correlates with prognosis. Cancer Epidemiol Biomarkers Prev 18: 2190-2194, 2009.
37. Blumke K, Bilkenroth U, Schmidt U, Melchior A, Fussel S, Bartel F, Heynemann H, Fornara P, Taubert H, Wirth MP and Meye A: Detection of circulating tumor cells from renal carcinoma patients: experiences of a two-center study. Oncol Rep 14: 895-899, 2005.
38. Hioki T and Sugimura Y: Detection of circulating cancer cells by nested reverse transcription-polymerase chain reaction of cytokeratin-19 in patients with renal cell carcinoma. Hinyokika Kiyo 45: 577-581, 1999 (in Japanese).
39. McKiernan JM, Buttyan R, Bander NH, de la Taille A, Stifelman MD, Emanuel ER, Bagiella E, Rubin MA, Katz AE, Olsson CA and Sawczuk IS: The detection of renal carcinoma cells in the peripheral blood with an enhanced reverse transcriptase-polymerase chain reaction assay for MN/CA9. Cancer 86: 492-497, 1999.
40. Shimazui T, Yoshikawa K, Uemura H, Kawamoto R, Kawai K, Uchida K, Hirao Y, Saga S and Akaza H: Detection of cadherin-6 mRNA by nested RT-PCR as a potential marker for circulating cancer cells in renal cell carcinoma. Int J Oncol 23: 1049-1054, 2003.
41. Ashida S, Okuda H, Chikazawa M, Tanimura M, Sugita O, Yamamoto Y, Nakamura S, Moriyama M and Shuin T: Detection of circulating cancer cells with von Hippel-Lindau gene mutation in peripheral blood of patients with renal cell carcinoma. Clin Cancer Res 6: 3817-3822, 2000.
42. Li G, Passebosc-Faure K, Gentil-Perret A, Lambert C, Genin C and Tostain J: Cadherin-6 gene expression in conventional renal cell carcinoma: a useful marker to detect circulating tumor cells. Anticancer Res 25: 377-381, 2005. (Pubitemid 40470133)
43. Buchner A, Riesenberg R, Kotter I, Crispin A, Hofstetter A and Oberneder R: Detection and prognostic value of cytokeratin positive tumor cells in bone marrow of patients with renal cell carcinoma. J Urol 170: 1747-1751, 2003. (Pubitemid 37254920)
44. Buchner A, Riesenberg R, Kotter I, Hofstetter A, Stief C and Oberneder R: Frequency and prognostic relevance of disseminated tumor cells in bone marrow of patients with metastatic renal cell carcinoma. Cancer 106: 1514-1520, 2006.
45. Naoe M, Ogawa Y, Morita J, Omori K, Takeshita K, Shichijyo T, Okumura T, Igarashi A, Yanaihara A, Iwamoto S, Fukagai T, Miyazaki A and Yoshida H: Detection of circulating urothelial cancer cells in the blood using the CellSearch System. Cancer 109: 1439-1445, 2007. (Pubitemid 46466573)
46. Rink M, Chun FK, Minner S, Friedrich M, Mauermann O, Heinzer H, Huland H, Fisch M, Pantel K and Riethdorf S: Detection of circulating tumour cells in peripheral blood of patients with advanced non-metastatic bladder cancer. BJU Int 107: 1668-1675, 2011.
47. Gradilone A, Petracca A, Nicolazzo C, Gianni W, Cortesi E, Naso G, Vincenzi B, Cristini C, De Berardinis E, Di Silverio F, Agliano AM and Gazzaniga P: Prognostic significance of survivin-expressing circulating tumour cells in T1G3 bladder cancer. BJU Int 106: 710-715, 2010.